Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMALIZUMAB Cause Forced expiratory volume abnormal? 31 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Forced expiratory volume abnormal have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.1% of all adverse event reports for OMALIZUMAB.

31
Reports of Forced expiratory volume abnormal with OMALIZUMAB
0.1%
of all OMALIZUMAB reports
0
Deaths
10
Hospitalizations

How Dangerous Is Forced expiratory volume abnormal From OMALIZUMAB?

Of the 31 reports, 10 (32.3%) required hospitalization, and 1 (3.2%) were considered life-threatening.

Is Forced expiratory volume abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 31 reports have been filed with the FAERS database.

What Other Side Effects Does OMALIZUMAB Cause?

No adverse event (9,736) Asthma (9,354) Urticaria (9,231) Off label use (9,199) Dyspnoea (8,323) Drug ineffective (6,747) Cough (5,926) Pruritus (5,224) Fatigue (5,053) Malaise (4,820)

What Other Drugs Cause Forced expiratory volume abnormal?

ALBUTEROL (30) MEPOLIZUMAB (24) TIOTROPIUM (20) BUDESONIDE\FORMOTEROL (14) PREDNISONE (12) FLUTICASONE\SALMETEROL (11) ALBUTEROL\IPRATROPIUM (10) AZTREONAM LYSINE (10) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (10) TERBUTALINE (9)

Which OMALIZUMAB Alternatives Have Lower Forced expiratory volume abnormal Risk?

OMALIZUMAB vs OMAVELOXOLONE OMALIZUMAB vs OMBITASVIR OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS

Related Pages

OMALIZUMAB Full Profile All Forced expiratory volume abnormal Reports All Drugs Causing Forced expiratory volume abnormal OMALIZUMAB Demographics